Home
>
National Drug Code (NDC)
>
Quinapril
Quinapril - 65862-617-30 - (Quinapril Hydrochloride)
Drug Information of Quinapril
| Product NDC: | 65862-617 |
| Proprietary Name: | Quinapril |
| Non Proprietary Name: | Quinapril Hydrochloride |
| Active Ingredient(s): | 5 mg/1 & nbsp; Quinapril Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Quinapril
| Product NDC: | 65862-617 |
| Labeler Name: | Aurobindo Pharma Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA202725 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130429 |
Package Information of Quinapril
| Package NDC: | 65862-617-30 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (65862-617-30) |
NDC Information of Quinapril
| NDC Code | 65862-617-30 |
| Proprietary Name | Quinapril |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (65862-617-30) |
| Product NDC | 65862-617 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Quinapril Hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20130429 |
| Marketing Category Name | ANDA |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | QUINAPRIL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
